Molecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies
Collaboration leverages lead-based (212Pb) alpha emitter expertise and supply of Orano Med with Molecular Partners’ leadership in DARPins for tumor-targeted […]